[1]
Sapitri, D.Z., Mareta, F. and Anggraini, D. 2026. Corporate Governance, Profitability, and Financial Statement Fraud Risk in Indonesian Pharmaceutical Companies. Jurnal Relevansi : Ekonomi, Manajemen dan Bisnis. 10, 4 (Aug. 2026), 879–895. DOI:https://doi.org/10.61401/relevansi.v10i4.626.